Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here are three stocks where Wall Street’s estimates seem disconnected from reality and some better opportunities to consider.
Box (BOX)
Consensus Price Target: $36.89 (15.8% implied return)
Founded in 2005 by Aaron Levie and Dylan Smith, Box (NYSE: BOX) provides organizations with software to securely store, share and collaborate around work documents in the cloud.
Why Does BOX Give Us Pause?
- 7.6% annual revenue growth over the last three years was slower than its software peers
- Offerings struggled to generate meaningful interest as its average billings growth of 4.7% over the last year did not impress
- Estimated sales growth of 6% for the next 12 months implies demand will slow from its three-year trend
Box is trading at $31 per share, or 3.9x forward price-to-sales. Dive into our free research report to see why there are better opportunities than BOX.
Hilton Grand Vacations (HGV)
Consensus Price Target: $45.20 (41.2% implied return)
Spun off from Hilton Worldwide in 2017, Hilton Grand Vacations (NYSE: HGV) is a global timeshare company that provides travel experiences for its customers through its timeshare resorts and club membership programs.
Why Are We Cautious About HGV?
- 14% annual revenue growth over the last two years was slower than its consumer discretionary peers
- ROIC of 3.6% reflects management’s challenges in identifying attractive investment opportunities
- High net-debt-to-EBITDA ratio of 13× could force the company to raise capital at unfavorable terms if market conditions deteriorate
At $34.78 per share, Hilton Grand Vacations trades at 11x forward price-to-earnings. Read our free research report to see why you should think twice about including HGV in your portfolio.
Teleflex (TFX)
Consensus Price Target: $236.68 (24.4% implied return)
With a portfolio spanning from vascular access catheters to minimally invasive surgical tools, Teleflex (NYSE: TFX) designs, manufactures, and supplies single-use medical devices used in critical care and surgical procedures across hospitals worldwide.
Why Does TFX Worry Us?
- Weak constant currency growth over the past two years indicates challenges in maintaining its market share
- Demand is forecasted to shrink as its estimated sales for the next 12 months are flat
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
Teleflex’s stock price of $132.07 implies a valuation ratio of 8.6x forward price-to-earnings. Check out our free in-depth research report to learn more about why TFX doesn’t pass our bar.
Stocks We Like More
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.
Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free.
